This is a preview of subscription content, log in via an institution to check access.
Reference
Patel C, et al. Health Outcomes Among Patients Diagnosed with Schizophrenia in the US Veterans Health Administration Population Who Transitioned from Once-Monthly to Once-Every-3-Month Paliperidone Palmitate: An Observational Retrospective Analysis. Advances in Therapy : 8 Aug 2019
Rights and permissions
About this article
Cite this article
Once-every-3-month paliperidone palmitate costs evaluated. PharmacoEcon Outcomes News 835, 23 (2019). https://doi.org/10.1007/s40274-019-6160-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-6160-7